JPMORGAN CHASE & CO - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 75 filers reported holding DESIGN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$132,967
-59.4%
56,342
+8.4%
0.00%
Q2 2023$327,494
+118.3%
51,983
+100.3%
0.00%
Q1 2023$150,000
+73791.6%
25,956
+31.1%
0.00%
Q4 2022$203
-100.0%
19,800
-78.7%
0.00%
Q3 2022$1,559,000
+509.0%
93,152
+409.3%
0.00%
Q2 2022$256,000
-21.7%
18,289
-9.6%
0.00%
Q1 2022$327,000
-3.0%
20,239
+28.6%
0.00%
Q4 2021$337,000
+180.8%
15,735
+93.4%
0.00%
Q3 2021$120,000
-24.5%
8,137
+1.8%
0.00%
Q2 2021$159,0007,9950.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$15,402,4837.89%
Logos Global Management LP 5,032,501$11,876,7021.58%
Prosight Management, LP 1,203,745$2,840,8380.90%
TANG CAPITAL MANAGEMENT LLC 1,350,000$3,186,0000.45%
Soleus Capital Management, L.P. 1,025,000$2,419,0000.22%
RTW INVESTMENTS, LP 2,512,986$5,930,6470.12%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 180,000$425,0000.09%
Corton Capital Inc. 27,134$64,0360.03%
OCCUDO QUANTITATIVE STRATEGIES LP 100,722$237,7040.03%
Rock Springs Capital Management LP 460,391$1,086,5230.03%
View complete list of DESIGN THERAPEUTICS INC shareholders